Pyrvinium targets autophagy addiction to promote cancer cell death
Open Access
- 2 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 4 (5), e614
- https://doi.org/10.1038/cddis.2013.142
Abstract
Autophagy is a cellular catabolic process by which long-lived proteins and damaged organelles are degradated by lysosomes. Activation of autophagy is an important survival mechanism that protects cancer cells from various stresses, including anticancer agents. Recent studies indicate that pyrvinium pamoate, an FDA-approved antihelminthic drug, exhibits wide-ranging anticancer activity. Here we demonstrate that pyrvinium inhibits autophagy both in vitro and in vivo. We further demonstrate that the inhibition of autophagy is mammalian target of rapamycin independent but depends on the transcriptional inhibition of autophagy genes. Moreover, the combination of pyrvinium with autophagy stimuli improves its toxicity against cancer cells, and pretreatment of cells with 3-MA or siBeclin1 partially protects cells from pyrvinium-induced cell death under glucose starvation, suggesting that targeted autophagy addiction is involved in pyrvinium-mediated cytotoxicity. Finally, in vivo studies show that the combination therapy of pyrvinium with the anticancer and autophagy stimulus agent, 2-deoxy-D-glucose (2-DG), is significantly more effective in inhibiting tumor growth than pyrvinium or 2-DG alone. This study supports a novel cancer therapeutic strategy based on targeting autophagy addiction and implicates using pyrvinium as an autophagy inhibitor in combination with chemotherapeutic agents to improve their therapeutic efficacy.Keywords
This publication has 40 references indexed in Scilit:
- Elevated Inflammatory Response in Caveolin-1-deficient Mice with Pseudomonas aeruginosa Infection Is Mediated by STAT3 Protein and Nuclear Factor κB (NF-κB)Journal of Biological Chemistry, 2011
- Inducing Indigestion: Companies Embrace Autophagy InhibitorsJNCI Journal of the National Cancer Institute, 2011
- Principles and Current Strategies for Targeting Autophagy for Cancer TreatmentClinical Cancer Research, 2011
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1Nature, 2011
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1αNature Chemical Biology, 2010
- Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine diseaseHuman Molecular Genetics, 2010
- Network organization of the human autophagy systemNature, 2010
- Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activityNature, 2010
- Non-competitive androgen receptor inhibition in vitro and in vivoProceedings of the National Academy of Sciences of the United States of America, 2009
- Mechanism of Cancer Cell Adaptation to Metabolic StressMolecular & Cellular Proteomics, 2009